Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 1728


Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.

Hosseinipour MC, Bisson GP, Miyahara S, Sun X, Moses A, Riviere C, Kirui FK, Badal-Faesen S, Lagat D, Nyirenda M, Naidoo K, Hakim J, Mugyenyi P, Henostroza G, Leger PD, Lama JR, Mohapi L, Alave J, Mave V, Veloso VG, Pillay S, Kumarasamy N, Bao J, Hogg E, Jones L, Zolopa A, Kumwenda J, Gupta A; Adult AIDS Clinical Trials Group A5274 (REMEMBER) Study Team.

Lancet. 2016 Mar 19;387(10024):1198-209. doi: 10.1016/S0140-6736(16)00546-8.


Why are people living with HIV still dying of tuberculosis?

Godfrey-Faussett P, Ayles H.

Lancet. 2016 Mar 19;387(10024):1141-3. doi: 10.1016/S0140-6736(16)00699-1. No abstract available.


Progress in Reversing the HIV Epidemic through Intensified Access to Antiretroviral Therapy: Results from a Nationally Representative Population-Based Survey in Kenya, 2012.

Kim AA, Mukui I, N'gan'ga L, Katana A, Koros D, Wamicwe J, De Cock KM; KAIS Study Group.

PLoS One. 2016 Mar 1;11(3):e0148068. doi: 10.1371/journal.pone.0148068. eCollection 2016.


Implementation and Operational Research: Declining Tuberculosis Incidence Among People Receiving HIV Care and Treatment Services in East Africa, 2007-2012.

Saito S, Mpofu P, Carter EJ, Diero L, Wools-Kaloustian KK, Yiannoutsos CT, Beverly MS, Tsiouris S, Somi GR, Ssali J, Nash D, Elul B.

J Acquir Immune Defic Syndr. 2016 Apr 1;71(4):e96-e106. doi: 10.1097/QAI.0000000000000896.


Implementation and Operational Research: Feasibility of Using Tuberculin Skin Test Screening for Initiation of 36-Month Isoniazid Preventive Therapy in HIV-Infected Patients in Resource-Constrained Settings.

Huerga H, Mueller Y, Ferlazzo G, Mpala Q, Bevilacqua P, Vasquez B, Noël Mekiedje C, Ouattara A, Mchunu G, Weyenga HO, Varaine F, Bonnet M.

J Acquir Immune Defic Syndr. 2016 Apr 1;71(4):e89-95. doi: 10.1097/QAI.0000000000000895.


Trends in CD4 Count Testing, Retention in Pre-ART Care, and ART Initiation Rates over the First Decade of Expansion of HIV Services in Haiti.

Koenig SP, Bernard D, Dévieux JG, Atwood S, McNairy ML, Severe P, Marcelin A, Julma P, Apollon A, Pape JW.

PLoS One. 2016 Feb 22;11(2):e0146903. doi: 10.1371/journal.pone.0146903. eCollection 2016.


[Survival time and associated factors of 8 310 AIDS patients initially receiving antiretroviral treatment of Liangshan Yi Autonomous Prefecture, Sichuan province of China].

Zhang G, Gong Y, Wang Q, Zhang S, Liao Q, Yu G, Wang K, Wang J, Ye S, Liu Z.

Zhonghua Yu Fang Yi Xue Za Zhi. 2015 Nov;49(11):967-72. Chinese.


[Impact of etiotropic therapy on the immune status of patients with HIV infection and tuberculosis].

Zimina VN, Kravchenko AV.

Ter Arkh. 2015;87(11):37-41. Russian.


A Randomized, Controlled Safety, and Immunogenicity Trial of the M72/AS01 Candidate Tuberculosis Vaccine in HIV-Positive Indian Adults.

Kumarasamy N, Poongulali S, Bollaerts A, Moris P, Beulah FE, Ayuk LN, Demoitié MA, Jongert E, Ofori-Anyinam O.

Medicine (Baltimore). 2016 Jan;95(3):e2459. doi: 10.1097/MD.0000000000002459.


[Influential factors analysis on the survival time of patients infected with tuberculosis and HIV].

Zheng Z, Tang Z, Lu Q, Wei H, Geng W.

Zhonghua Yu Fang Yi Xue Za Zhi. 2015 Oct;49(10):907-13. Chinese.


Viral Load and Risk of Tuberculosis in HIV Infection.

Lange C, van Leth F, Sester M; TBnet.

J Acquir Immune Defic Syndr. 2016 Feb 1;71(2):e51-3. doi: 10.1097/QAI.0000000000000834. No abstract available.


Major Challenges in Clinical Management of TB/HIV Coinfected Patients in Eastern Europe Compared with Western Europe and Latin America.

Efsen AM, Schultze A, Post FA, Panteleev A, Furrer H, Miller RF, Losso MH, Toibaro J, Skrahin A, Miro JM, Caylà JA, Girardi E, Bruyand M, Obel N, Podlekareva DN, Lundgren JD, Mocroft A, Kirk O; TB:HIV study group in EuroCoord.

PLoS One. 2015 Dec 30;10(12):e0145380. doi: 10.1371/journal.pone.0145380. eCollection 2015.


Progress and challenges in implementing HIV care and treatment policies in Latin America following the treatment 2.0 initiative.

Perez F, Gomez B, Ravasi G, Ghidinelli M.

BMC Public Health. 2015 Dec 19;15:1260. doi: 10.1186/s12889-015-2565-9.


Determinants of Anemia Among Human Immunodeficiency Virus-Positive Adults at Care and Treatment Clinics in Dar es Salaam, Tanzania.

Petraro P, Duggan C, Spiegelman D, Hertzmark E, Makubi A, Chalamilla G, Siril H, Sando D, Aboud S, Fawzi WW.

Am J Trop Med Hyg. 2016 Feb;94(2):384-92. doi: 10.4269/ajtmh.15-0587. Epub 2015 Dec 14.


The Global Health Impact Index: Promoting Global Health.

Hassoun N.

PLoS One. 2015 Dec 11;10(12):e0141374. doi: 10.1371/journal.pone.0141374. eCollection 2015. Erratum in: PLoS One. 2016;11(2):e0148946.


Infectious Diseases of Poverty in Children: A Tale of Two Worlds.

Hansen C, Paintsil E.

Pediatr Clin North Am. 2016 Feb;63(1):37-66. doi: 10.1016/j.pcl.2015.08.002. Review.


Strengthening HIV surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor HIV prevalence and incidence in the uMgungundlovu District, KwaZulu-Natal, South Africa.

Kharsany AB, Cawood C, Khanyile D, Grobler A, Mckinnon LR, Samsunder N, Frohlich JA, Abdool Karim Q, Puren A, Welte A, George G, Govender K, Toledo C, Chipeta Z, Zembe L, Glenshaw MT, Madurai L, Deyde VM, Bere A.

BMC Public Health. 2015 Nov 20;15:1149. doi: 10.1186/s12889-015-2179-2.


HIV testing uptake and retention in care of HIV-infected pregnant and breastfeeding women initiated on 'Option B+' in rural Zimbabwe.

Dzangare J, Takarinda KC, Harries AD, Tayler-Smith K, Mhangara M, Apollo TM, Mushavi A, Chimwaza A, Sithole N, Magure T, Mpofu A, Dube F, Mugurungi O.

Trop Med Int Health. 2016 Feb;21(2):202-9. doi: 10.1111/tmi.12637. Epub 2015 Dec 8.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk